Search results for "Edema"

showing 10 items of 625 documents

Langzeitverlauf 10 Jahre nach transpupillarer Thermotherapie (TTT) kleiner, posteriorer maligner Aderhautmelanome

2011

Background The aim of this study was to evaluate the long-term results of transpupillary thermotherapy (TTT) for small malignant choroidal melanomas. Patients and methods In the time period 1/1998 to 10/1999 in a prospective non-randomised analysis 26 eyes with small malignant melanomas (located posterior to the equator with base ≤ 12 and thickness ≤ 4.5 mm) were primary treated with the TTT standard protocol (follow-up over a time span of at least 10 years). Results Thirteen women and thirteen men (mean age: 64 years) underwent TTT. The mean preoperative tumour thickness was 2.45 mm (0.8 - 4.5 mm). Ten years postoperatively tumour regression without recurrence after 1.4 treatment sessions …

Tumour regressionmedicine.medical_specialtygenetic structuresLong term follow upbusiness.industryIris atrophyMacular oedemamedicine.diseaseeye diseasesMetastasisOphthalmologymedicine.anatomical_structureOphthalmologymedicineStandard protocolsense organsChoroidbusinessSynechiaKlinische Monatsblätter für Augenheilkunde
researchProduct

Práctica 8. Fisioterapia en el linfedema de miembros superiores

2011

El tratamiento multidisciplinar de un linfedema se basa en la aplicación de medidas para asistir el drenaje linfático, y así evitar alteraciones fibroescleróticas de la piel. Es decir, consiste en un tratamiento paliativo que pretende: 1) Disminuir el volumen; 2) Reducir los síntomas (dolor, pesadez, parestesias, etc.); 3) Evitar la evolución a estadios avanzados y la aparición de complicaciones. Para ello se recurre a las siguientes medidas fisioterápicas: el postural en declive, la respiración abdomino-diafragmática y torácica, el drenaje linfático manual, la presoterapia neumática, las medidas de contención-compresión y la cinesiterapia. El tractament multidisciplinar d’un limfedema es f…

UNESCO::CIENCIAS DE LA VIDA::Fisiología humana ::Fisiología cardiovascularfisioterapia;linfedema;medidas de contención-compresión;cinesiterapia;masoterapia;presoterapia neumáticaUNESCO::CIENCIAS MÉDICAS ::Patología::Patología cardiovascularUNESCO::CIENCIAS MÉDICAS ::Cirugía ::FisioterapiaUNESCO::CIENCIAS MÉDICAS ::Medicina del trabajo::Rehabilitación (médica)UNESCO::CIENCIAS MÉDICAS ::Cirugía ::Cirugía vascular
researchProduct

Práctica 6. Exploración clínica venosa

2011

La exploración clínico-funcional sigue siendo uno de los pilares fundamentales para el diagnóstico de los trastornos circulatorios. Es preferible iniciar la exploración con los métodos clásicos de Anamnesis y la exploración física para acabar con métodos diagnósticos instrumentales como: el Doppler venoso continuo, la Eco-Doppler, la Pletismografía de oclusión venosa la Flebografía-radioisotópica o radiológica, etc. L’exploració clínico-funcional continua sent un dels pilars fonamentals per al diagnòstico dels trastorns circulatoris. És preferible iniciar l’exploració amb els mètodes clàsics d’Anamnesi i l’exploració física per acabar amb els mètodes diagnòstics instrumentals com ara: el Do…

UNESCO::CIENCIAS MÉDICAS ::Patología::Patología cardiovascularUNESCO::CIENCIAS MÉDICAS ::Cirugía ::FisioterapiaFisioterapia;exploración clínica;insuficiencia venosa;síndrome varicoso;fleboedema;trombosisUNESCO::CIENCIAS MÉDICAS ::Medicina del trabajo::Rehabilitación (médica)UNESCO::CIENCIAS MÉDICAS ::Patología::Trombosis
researchProduct

La sindrome orticaria-angioedema: una patologia internistica ad espressione cutanea. [Urticaria and angioedema. A general affection rather than a spe…

2004

Urticaria and angioedema will affect 15-20% of the general population during their lifetime, and this remains one of the most vexing conditions to evaluate and treat. This review of the literature is to give the reader a global insight into the spectrum of urticaria and angioedema, focusing on differential diagnosis and pathogenic mechanisms. It will define the role of the mast cell, exploring a possible autoimmune basis for urticaria. Last, the different potential treatments will be discussed. Urticaria and angioedema are frustrating problems for both physicians and their patients; however, the problem may best be approached by considering urticaria as a general affection rather than a spe…

UrticariaAngioedemaMast cell
researchProduct

Tbx1 regulates Vegfr3 and is required for lymphatic vessel development

2010

Defects in lymphangiogenesis are added to the broad clinical manifestations of DiGeorge syndrome, caused by deletion of the T box transcription factor Tbx1.

Vascular Endothelial Growth Factor ATBX1Cellular differentiationBiologyMice03 medical and health sciences0302 clinical medicinestomatognathic systemReportLymphatic vesselmedicineAnimalsHumansLymphangiogenesisEnhancerCells CulturedResearch ArticlesLymphatic Vessels030304 developmental biology0303 health sciencesABNORMAL CAROTID ARTERIES; TRANSGENIC MICE; VELOCARDIOFACIAL SYNDROME; CARDIOVASCULAR DEFECTS; LYMPHANGIOGENESIS; LYMPHEDEMA; MOUSE; RECEPTOR-3; MUTATION; SYSTEMEndothelial CellsGene Expression Regulation DevelopmentalCell DifferentiationCell BiologyEmbryo Mammalian3. Good healthLymphangiogenesisCell biologyVascular endothelial growth factor ALymphatic systemmedicine.anatomical_structureVascular endothelial growth factor Cembryonic structuresImmunologyT-Box Domain Proteins030217 neurology & neurosurgeryJournal of Cell Biology
researchProduct

Risk of Death Associated With Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: A Systematic Review and Meta-analysis.

2020

Importance Although intravitreal anti–vascular endothelial growth factor (VEGF) treatment represents the first-line therapy for many retinal diseases, the issue of their systemic safety is debatable. Objectives To assess whether intravitreal anti-VEGF therapy might be associated with increased risk of mortality and which variables are associated with the increase. Data Sources PubMed, MEDLINE, and Embase databases, the Cochrane Library, and ClinicalTrials.gov were systematically searched from inception to May 6, 2019. Study Selection Randomized clinical trials comparing intravitreal anti-VEGF treatment with control groups and with follow-up of at least 6 months were selected. Data Extractio…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyDatabases FactualMEDLINEAngiogenesis InhibitorsCochrane LibraryMacular Edemalaw.inventionRandomized controlled triallawFrequentist inferenceInternal medicineCause of DeathRetinal Vein OcclusionMedicineHumansanti-VEGF therapyrisk of mortality anti-vascular endothelial growth factor mortalityCause of deathOriginal InvestigationRandomized Controlled Trials as TopicDiabetic Retinopathybusiness.industryMortality rateOdds ratioChoroidal NeovascularizationOphthalmologyMeta-analysisIntravitreal InjectionsWet Macular DegenerationbusinessJAMA ophthalmology
researchProduct

Intravitreal dexamethasone implant versus anti-vascular endothelial growth factor therapy combined with cataract surgery in patients with diabetic ma…

2021

Objective: to compare outcomes of cataract surgery combined with either anti-Vascular Endothelial Growth Factor (anti-VEGF) therapy or dexamethasone implant (DEX) in patients with diabetic macular oedema (DMO). Methods: Pubmed and Embase databases were searched for studies reporting outcomes of diabetic cataract surgery combined with either anti-VEGF or DEX, with a follow-up ≥3 months. The primary outcome was the mean change in central macular thickness (CMT). Mean change in best corrected visual acuity (BCVA) was considered as a secondary outcome. The mean difference between baseline and post-treatment values (MD) with 95%-Confidence Interval (95%CI) was calculated and meta-analyses were p…

Vascular Endothelial Growth Factor Amedicine.medical_specialtygenetic structuresmedicine.medical_treatmentVisual AcuityEndothelial Growth FactorsMacular EdemaDexamethasoneCataractOphthalmologyDiabetes MellitusHumansMedicineIn patientDexamethasoneDiabetic Retinopathybusiness.industryDEXcataract surgeryCataract surgeryDiabetic cataractBevacizumabOphthalmologyAnti–vascular endothelial growth factor therapyDiabetic macular oedemaanti-VEGFdiabetic macular oedemaMeta-analysissense organsImplantbusinessmedicine.drugEye
researchProduct

Idiopathic Seidlmayer's Purpura: A Case Report

2014

Acute hemorrhagic edema of infancy (AHEI) was considered a rare form of Henoch-Schönlein purpura; however, it is now regarded as an independent disease typically involving patients aged 4-24 months. The authors describe the clinical case of a toddler aged 8 months, with skin erythematous pomphoid<b> </b>lesions, treated at home with topical steroids without benefits. The appearance of new lesions and the worsening of the previous skin signs induced the parents to drive the child to the hospital. The medical history revealed the administration of a vaccine dose 2 months before.

Vasculitismedicine.medical_specialtySeidlmayer's purpuraDermatologyDiseaseAcute hemorrhagic edema of infancyPublished online: May 2014Settore MED/38 - Pediatria Generale E Specialisticalcsh:DermatologymedicineCorticosteroidsCorticosteroidMedical historyToddlerbusiness.industryAcute hemorrhagic edema of infancylcsh:RL1-803medicine.diseaseDermatologySurgeryPurpuraClinical casemedicine.symptombusinessVasculitisSeidlmayer’s purpura
researchProduct

Mechanical ventilation in patients with cardiogenic pulmonary edema: a sub-analysis of the LUNG SAFE study

2022

Supported by Centro de Investigación Biomédica en Red (CIBER)‑Enfermedades respiratorias, Madrid, Spain (CB17/06/00021) and Fundación para el Fomento en Asturias de la Investigación Científica aplicada y la tecnología (FICYT, AYUD2021/52014). RRG is the recipient of a grant from Instituto de Salud Carlos III, Madrid, Spain (CM20/00083).

Ventilator-induced lung injuryCardiogenic pulmonary edema; Driving pressure; Mechanical ventilation; Ventilator-induced lung injurylnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]Mechanical ventilationCardiogenic pulmonary edemaSettore MED/41 - ANESTESIOLOGIADriving pressureCritical Care and Intensive Care Medicine
researchProduct

Surgical Treatment for Traumatic Brain Injury: Is It Time for Reappraisal?

2015

Traumatic brain injury (TBI) is a major cause of morbidity and mortality in the United States. It is estimated that each year, on average, TBIs associated with 1.1 million visits to the emergency department, 235,000 hospitalizations, and 50,000 deaths.

Ventriculostomymedicine.medical_specialtyTraumatic brain injurymedicine.medical_treatmentTreatment outcomeBrain EdemaVentriculostomyBrain InjuriemedicineSurgical treatmentSurvival rateCraniotomybusiness.industryBrain edemaMedicine (all)medicine.diseaseDecompression SurgicalSurgerySurvival RateTreatment OutcomeAnesthesiaSurgeryNeurology (clinical)Intracranial HypertensionbusinessCraniotomyHuman
researchProduct